HeartSciences (HSCS) Equity Average (2021 - 2026)

HeartSciences (HSCS) has 6 years of Equity Average data on file, last reported at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 17.77% year-over-year to $3.4 million; the trailing twelve-month figure through Jan 2026 stood at $3.4 million (up 17.77% YoY), and the FY2025 full-year result was $3.8 million, changed 0.34% from the prior year.
• Equity Average for Q1 2026 stood at $3.4 million, down from $3.7 million in the prior quarter.
• Across five years, Equity Average topped out at $8.0 million in Q2 2024 and bottomed at -$5.1 million in Q2 2022.
• The 5-year median for Equity Average is $1.7 million (2025), against an average of $1.6 million.
• The widest annual swing landed in 2023, when Equity Average tumbled 154.65%; it then soared 58411.6% in 2024.
• A 5-year view of Equity Average shows it stood at $2.0 million in 2022, then tumbled by 154.65% to -$1.1 million in 2023, then soared by 558.69% to $5.0 million in 2024, then decreased by 26.4% to $3.7 million in 2025, then slipped by 6.68% to $3.4 million in 2026.
• The last three Equity Average figures came in at $3.4 million (Q1 2026), $3.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison